Terminated PHASE2 INTERVENTIONAL NCT00515255

Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)

Open-Label Exploratory Investigation Of NPL-2003 In Adolescents With Obsessive Compulsive Disorder

Sponsor: Neuropharm

Conditions Obsessive Compulsive Disorder

Interventions Minocycline

Updated 6 times since 2017 Last updated: Apr 26, 2012 Started: Jul 31, 2007 Primary completion: Apr 30, 2008 Completion: Apr 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment Goal of 20 Not Met

Listed as NCT00515255, this PHASE2 trial focuses on Obsessive Compulsive Disorder and remains terminated or withdrawn. Sponsored by Neuropharm, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Neuropharm

Data source: Neuropharm

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States
• New York, United States